title: Antidepressant treatment response: 'I want it all, and I want it now!'†.
abstract: The treatment of depression remains suboptimal, highlighting the need for more effective antidepressants. Traditional drug discovery and development is time-consuming and costly, prompting the need for faster translation of novel therapies into practice. But clinical expediency comes at a cost against which potential benefits need to be considered judiciously.
authors.affiliation: Gin S. Malhi, Professor and Chair of Psychiatry, and Associate Director Kolling Institute, University of Sydney, Australia; Anne R. Lingford-Hughes, Professor of Addiction Biology, Centre for Neuropsychopharmacology, Division of Brain Sciences, Department of Medicine, Imperial College London, UK; Allan H. Young, Chair of Mood Disorders and Director of Centre for Affective Disorders, Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK gin.malhi@sydney.edu.au.
authors.forename: Gin S
authors.initials: GS
authors.lastname: Malhi
authors.affiliation: Gin S. Malhi, Professor and Chair of Psychiatry, and Associate Director Kolling Institute, University of Sydney, Australia; Anne R. Lingford-Hughes, Professor of Addiction Biology, Centre for Neuropsychopharmacology, Division of Brain Sciences, Department of Medicine, Imperial College London, UK; Allan H. Young, Chair of Mood Disorders and Director of Centre for Affective Disorders, Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.
authors.forename: Anne R
authors.initials: AR
authors.lastname: Lingford-Hughes
authors.affiliation: Gin S. Malhi, Professor and Chair of Psychiatry, and Associate Director Kolling Institute, University of Sydney, Australia; Anne R. Lingford-Hughes, Professor of Addiction Biology, Centre for Neuropsychopharmacology, Division of Brain Sciences, Department of Medicine, Imperial College London, UK; Allan H. Young, Chair of Mood Disorders and Director of Centre for Affective Disorders, Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.
authors.forename: Allan H
authors.initials: AH
authors.lastname: Young
mesh_terms: D000928:Antidepressive Agents / Q000627:therapeutic use*; D003863:Depression / Q000188:drug therapy*; D003866:Depressive Disorder / Q000188:drug therapy; D006801:Humans
chemical_list: D000928:Antidepressive Agents